Ask AI

Clinical Focus: From Mechanism to Management—Novel C5 Inhibitors in Generalized Myasthenia Gravis

This online curriculum features expert insight, patient perspectives, an audio podcast, an interactive clinical module, downloadable slides, and ClinicalThought commentary on novel C5 inhibitors in gMG. Across iterative, expert-led online educational activities, learners will examine mechanisms, efficacy, and safety data, patient selection, shared decision-making, and strategies to support symptom control, adherence, and long-term outcomes.

Share

Program Content

Activities

gMG C5 Inhibitors
gMG C5 Inhibitors: Matching Therapy to Patient Needs
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2026

Activities

Myasthenia Gravis Management
Clinical Focus: From Mechanism to Management—Novel C5 Inhibitors in Generalized Myasthenia Gravis  
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2026

Expires: August 30, 2027

Myasthenia Gravis Management
Novel C5 Inhibitors in Generalized Myasthenia Gravis: Using Mechanism to Inform Management
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 31, 2026

Activities

Myasthenia Gravis Patient Story
Between Hope and Reality: A Lived Experience With Myasthenia Gravis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 18, 2026

Expires: August 18, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc